Literature DB >> 23572051

Concise review: stem cell therapies for neuropathic pain.

Veronica R Fortino1, Daniel Pelaez, Herman S Cheung.   

Abstract

Neuropathic pain is a chronic condition that is heterogeneous in nature and has different causes. Different from and more burdensome than nociceptive pain, neuropathic pain more severely affects people's quality of life. Understanding the various mechanisms of the onset and progression of neuropathic pain is important in the development of an effective treatment. Research is being done to replace current pharmacological treatments with cellular therapies that will have longer lasting effects. Stem cells present an exciting potential therapy for neuropathic pain. In this review, we describe the neuroprotective effects of stem cells along with special emphasis on the current translational research using stem cells to treat neuropathic pain.

Entities:  

Keywords:  Adult stem cells; Cellular therapy; Neuropathy; Stem cell-microenvironment interactions

Mesh：

Year:  2013        PMID： 23572051      PMCID： PMC3667564          DOI： 10.5966/sctm.2012-0122

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN： 2157-6564            Impact factor:   6.940


  24 in total

1.  Early onset of spontaneous activity in uninjured C-fiber nociceptors after injury to neighboring nerve fibers.

Authors:  G Wu; M Ringkamp; T V Hartke; B B Murinson; J N Campbell; J W Griffin; R A Meyer
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

Review 2.  Mechanisms of disease: neuropathic pain--a clinical perspective.

Authors:  Ralf Baron
Journal:  Nat Clin Pract Neurol       Date:  2006-02

Review 3.  Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain.

Authors:  Tuan Trang; Simon Beggs; Michael W Salter
Journal:  Neuron Glia Biol       Date:  2012-05-22

Review 4.  Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.

Authors:  Ralf Baron; Andreas Binder; Gunnar Wasner
Journal:  Lancet Neurol       Date:  2010-08       Impact factor: 44.182

5.  Neuroprotective effects of mesenchymal stem cell transplantation in animal model of cerebellar degeneration.

Authors:  Mohammad Amin Edalatmanesh; Ahmad Reza Bahrami; Ebrahim Hosseini; Mahmoud Hosseini; Saeid Khatamsaz
Journal:  Neurol Res       Date:  2011-11       Impact factor: 2.448

6.  Nerve repair with adipose-derived stem cells protects dorsal root ganglia neurons from apoptosis.

Authors:  A J Reid; M Sun; M Wiberg; S Downes; G Terenghi; P J Kingham
Journal:  Neuroscience       Date:  2011-10-06       Impact factor: 3.590

7.  Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community.

Authors:  Blair H Smith; Nicola Torrance; Michael I Bennett; Amanda J Lee
Journal:  Clin J Pain       Date:  2007-02       Impact factor: 3.442

8.  Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.

Authors:  Feifei Wang; Takao Yasuhara; Tetsuro Shingo; Masahiro Kameda; Naoki Tajiri; Wen Ji Yuan; Akihiko Kondo; Tomohito Kadota; Tanefumi Baba; Judith Thomas Tayra; Yoichiro Kikuchi; Yasuyuki Miyoshi; Isao Date
Journal:  BMC Neurosci       Date:  2010-04-26       Impact factor: 3.288

9.  Bone marrow-derived mesenchymal stem cells improve the functioning of neurotrophic factors in a mouse model of diabetic neuropathy.

Authors:  Bae Jin Kim; Hee Kyung Jin; Jae-Sung Bae
Journal:  Lab Anim Res       Date:  2011-06-22

10.  Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice.

Authors:  Dario Siniscalco; Catia Giordano; Umberto Galderisi; Livio Luongo; Vito de Novellis; Francesco Rossi; Sabatino Maione
Journal:  Front Integr Neurosci       Date:  2011-12-01
View more
  13 in total

1.  Activating transcription factor 4 modulates BDNF release from microglial cells.

Authors:  Pengling Sun; Xiangnan Li; Chengwen Chen; Qianbo Chen; Qing Ouyang; Fangting Liu; Zhenghua Xiang; Hongbin Yuan
Journal:  J Mol Neurosci       Date:  2013-09-27       Impact factor: 3.444

2.  Intrathecal Injection of Human Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorates Neuropathic Pain in Rats.

Authors:  Chunxiu Chen; Fengfeng Chen; Chengye Yao; Shaofang Shu; Juan Feng; Xiaoling Hu; Quan Hai; Shanglong Yao; Xiangdong Chen
Journal:  Neurochem Res       Date:  2016-09-21       Impact factor: 3.996

3.  Fe3O4@Polydopamine-Labeled MSCs Targeting the Spinal Cord to Treat Neuropathic Pain Under the Guidance of a Magnetic Field.

Authors:  Meichen Liu; Weijia Yu; Fuqiang Zhang; Te Liu; Kai Li; Meng Lin; Ying Wang; Guoqing Zhao; Jinlan Jiang
Journal:  Int J Nanomedicine       Date:  2021-05-11

4.  The christchurch earthquake: crush injury, neuropathic pain, and posttraumatic stress disorder.

Authors:  Frances Cammack; Edward A Shipton
Journal:  Case Rep Med       Date:  2013-07-11

Review 5.  Recent advances of stem cell therapy for retinitis pigmentosa.

Authors:  Yuxi He; Yan Zhang; Xin Liu; Emma Ghazaryan; Ying Li; Jianan Xie; Guanfang Su
Journal:  Int J Mol Sci       Date:  2014-08-20       Impact factor: 5.923

6.  Analgesia for neuropathic pain by dorsal root ganglion transplantation of genetically engineered mesenchymal stem cells: initial results.

Authors:  Hongwei Yu; Gregory Fischer; Allison D Ebert; Hsiang-En Wu; Xiaowen Bai; Quinn H Hogan
Journal:  Mol Pain       Date:  2015-02-12       Impact factor: 3.395

7.  Conditioned Medium of Bone Marrow-Derived Mesenchymal Stromal Cells as a Therapeutic Approach to Neuropathic Pain: A Preclinical Evaluation.

Authors:  Kelly Barbosa Gama; Dourivaldo Silva Santos; Afrânio Ferreira Evangelista; Daniela Nascimento Silva; Adriano Costa de Alcântara; Ricardo Ribeiro Dos Santos; Milena Botelho Pereira Soares; Cristiane Flora Villarreal
Journal:  Stem Cells Int       Date:  2018-01-30       Impact factor: 5.443

8.  Derivation and characterization of sheep bone marrow-derived mesenchymal stem cells induced with telomerase reverse transcriptase.

Authors:  Xuemin Zhu; Zongzheng Liu; Wen Deng; Ziqiang Zhang; Yumei Liu; Lan Wei; Yuling Zhang; Liutao Zhou; Yuzhu Wang
Journal:  Saudi J Biol Sci       Date:  2017-01-23       Impact factor: 4.219

9.  Intrathecal administration of human bone marrow mesenchymal stem cells genetically modified with human proenkephalin gene decrease nociceptive pain in neuropathic rats.

Authors:  Yi Sun; Dengwen Zhang; Haifeng Li; Ruichun Long; Qiang Sun
Journal:  Mol Pain       Date:  2017-01       Impact factor: 3.395

10.  MicroRNA-547-5p-mediated interleukin-33/suppressor of tumorigenicity 2 signaling underlies the genesis and maintenance of neuropathic pain and is targeted by the therapy with bone marrow stromal cells.

Authors:  Ju Zhou; Ting Zhuang; Peng Ma; Lidong Shan; Xiao-Dong Sun; Shan Gong; Jin Tao; Xian-Min Yu; Xinghong Jiang
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.